Award
Delivery Order #SPE2DR26FJQ1Q
AmerisourceBergen Drug Corp Awarded Delivery Order for Quillivant XR Suspension
Buyer
Defense Logistics Agency
Award Amount
$1,758.48
Ceiling
$1,758.48
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2DR26FJQ1Q
NAICS
424210
This award represents a delivery order contract under a broader indefinite delivery vehicle (IDV) secured by AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company. The contract entails the procurement of a specific pharmaceutical product, Quillivant XR 25 mg/5 ml suspension, indicating the government’s ongoing efforts to supply essential medications critical for patient care. The delivery order covers a short, defined period with precise fulfillment in a single location, emphasizing timely and reliable delivery within an established long-term supply framework. Originating from a competitive long-term agreement, this award supports healthcare operations by ensuring availability and consistent supply of vital medicines. The contract, part of a substantial pharmaceutical procurement program, highlights the government’s commitment to maintaining a stable and secure pharmaceutical supply chain critical to public health services.
Description
4571014540!QUILLIVANT XR 25 MG/5 ML SUSP 120ML